
Growth hormone axis
Tesamorelin 20mg
Stabilized GHRH analog
Overview
Stabilized GHRH analog
A stabilized analog of growth hormone-releasing hormone, modified at the N-terminus for increased resistance to enzymatic degradation. Supplied lyophilized for in-vitro study of GHRH receptor signaling.
- Fill: 20 mg / vial
- Pack: 1 vial · 20 mg total
- Purity: ≥99%
For in-vitro laboratory research use only. Not for human or animal consumption, medical, diagnostic or therapeutic use.
Receptor pharmacology
Sustained GHRH receptor stimulation of the anterior pituitary increases pulsatile GH release. Unlike exogenous HGH, endogenous pulsatility is preserved, and effects concentrate on visceral fat mobilization.
Laboratory handling
Research use disclaimer
Sacred Peptides does not provide dosing recommendations for human use. Tesamorelin 20mg is supplied for in-vitro laboratory research only. Any concentration ranges referenced on this page or in cited studies describe the parameters used in that research and are not instructions.
- Not a drug. Not approved by Health Canada or the FDA for human use.
- Not intended to diagnose, treat, cure, or prevent any disease.
- Not for use in humans, pregnant or nursing individuals, or animals outside a controlled research setting.
- Handling, storage, and disposal are the responsibility of a qualified researcher.